Close

Production & Manufacturing

GMP Fluid Handling: Regulatory Compliance Explained

Fluid Handling in GMP Manufacturing: The Essence of Regulatory Compliance Good Manufacturing Practices (GMP)GMP fluid handling compliance is a core aspect of biopharmaceutical manufacturing, ensuring all drugs meet the highest standards of quality, safety, and efficacy. Fluid handling systems are...

Single-Use Technologies in Biopharma Transform Manufacturing

The biopharmaceutical sector is being revolutionized by the demand for efficiency, increased safety, and sustainability. The core of this revolution is one of the greatest innovations in contemporary manufacturing single-use technologies in biopharma (SUTs). SUTs have changed the way...

Advances in Aseptic fluid transfer solutions

Sterility and Cross-Contamination: The Cornerstones of Modern Biopharma Manufacturing Biopharmaceutical production is all about sterility, accuracy, and safety. The risks are too high—patients who depend on these life-saving drugs expect nothing but the best, and sterility failure of any sort...

Green Chemistry in EU Shapes Pharmaceutical Intermediates

Green chemistry is a cutting-edge scientific discipline that focuses on developing environmentally friendly and sustainable chemical processes.  In the pharmaceutical industry, it has been gaining significant interest. Green chemistry in EU is transforming the production and usage of pharmaceutical...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing a dramatic shift, largely due to the repurposing and reformulation of pre-existing chemicals rather than the discovery of novel molecules.   Advances in specialty intermediates, which are essential for repurposing...

EU Green Regulations Impact Pharmaceutical Chemical Industry

Pharma specialty chemicals companies have been experiencing serious challenges based on the greening regulations enforced by the European Union. Such regulatory systems promote the harmonization of environmental stewardship and industrial development, yet they have become complex for the specialty...

Indian Pharma Grows 8% CAGR, Surpassing Global Average

The Indian pharma sector has seen 8% CAGR growth and at the same time has witnessed a 9% rise when it comes to export rates in 2024, as per one of the reports. McKinsey & Company’s report has shown...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read